Le Lézard
Classified in: Health, Business
Subjects: TNM, CHI, DIS

BlueSprig And FAC Partner To Build A National Leader In ABA Therapy Services


HOUSTON and ORLANDO, Fla. and ROSWELL, Ga., March 5, 2020 /PRNewswire/ -- Blue Sprig Pediatrics, Inc. ("BlueSprig") along with Florida Autism Center and Fusion Autism Center (together, "FAC") today announced a transformative partnership to create a top-five national provider and the leading provider in the Southern United States of Applied Behavior Analysis ("ABA") therapy services treating children with Autism Spectrum Disorder ("ASD"). Terms of the transaction were not disclosed.  

"The combination of BlueSprig and FAC is a landmark transaction that will significantly advance our shared mission of changing the world for children with autism," said Keith Jones, President and CEO of BlueSprig. "We are excited to partner with Kristy and the passionate team at FAC to enter into a new chapter of growth. Our enhanced scale and ability to share expertise and resources across our organizations will allow us to extend the reach of our platform, better serve existing and new clients, and collaborate with all stakeholders to advance clinical quality standards and reporting."

The Centers for Disease Control and Prevention ("CDC") estimate that one in 59 children in the U.S. are diagnosed with ASD by the age of eight. ABA is the gold standard of care for children diagnosed with ASD and BlueSprig and FAC are committed to partnering with providers and opening new clinics to increase access and fulfill the unmet need for high-quality behavior analysis treatment.  

"Our organizations share an absolute commitment to providing the highest-quality clinical services, and we believe our values and philosophies are a wonderful fit with one another," said Kristy Rohwedder, CEO of FAC. "We are delighted to join forces with Keith and the BlueSprig team to build a platform with national scale that will be able to deliver enhanced services and better navigation of the increasingly complex health care landscape."

The transaction follows a period of transformative growth for BlueSprig, which was formed in 2017 with the backing of KKR. Upon completion of the merger, BlueSprig and FAC will serve more than 1,800 families at nearly 110 clinics across 13 states. The combined company will have a leading position in the Southern United States, including the states of Florida, Georgia, Oklahoma, and Texas. KKR is providing new capital from its Health Care Strategic Growth Fund to fund the merger and support the continued growth of the combined company.

About Blue Sprig Pediatrics, Inc.
BlueSprig, founded in 2017, is a clinic-based provider of Applied Behavior Analysis ("ABA") therapy services to children with Autism Spectrum Disorder ("ASD"). BlueSprig is on a mission to change the world for children with autism and is committed to providing compassionate, individualized, and evidence-based behavior analysis treatment. Headquartered in Houston, TX, BlueSprig is the largest autism services provider in Texas with locations in Arizona, Arkansas, Illinois, Kentucky, Missouri, Ohio, Oklahoma, Oregon, South Carolina, and Washington. For additional information about BlueSprig or to receive updates, visit www.bluesprigautism.com 

About Florida Autism Center / Fusion Autism Center
Florida Autism Center was founded in 2005 and provides Applied Behavior Analysis ("ABA") treatment services to children diagnosed with Autism Spectrum Disorder ("ASD"). The company serves the autism community with center-based ABA therapy services across the state of Florida and in Georgia under the Fusion Autism Center brand. For additional information about the platform in Florida, please visit www.flautism.com, and for Georgia please visit www.fusionautism.com. 

Contacts:
Blue Sprig Pediatrics, Inc.
Laurie Marino
Director of Marketing and PR
[email protected]
832-240-5708

Florida Autism Center / Fusion Autism Center 
Courtney Albright
Vice President of Marketing
[email protected]
407-908-7353

 

SOURCE Blue Sprig Pediatrics, Inc.


These press releases may also interest you

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 05:00
Medical equipment manufacturing company Aohua Endoscopy clinched the Endoscopy Product Innovation Award at the recently held Healthcare Asia Medtech Awards 2024 for its development of the Aohua 4K AQ-300 video endoscopy system, which offers an...

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...



News published on and distributed by: